More on XENE
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $57.35 |
|
|||
| Open | $44.02 | ||||
| 52 Wk High | $9.75 | ||||
| 52 Wk Low | $5.65 | ||||
| Day High | $44.85 | ||||
| Day Low | $39.08 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 17,940,643 | ||||
- Xenon Pharmaceuticals (XENE) Reiterated at Buy by Stifel - MDD/BPD Study Enrollment Paused
- Xenon Pharmaceuticals (XENE) PT Lowered to $60 at Needham
- Xenon Pharmaceuticals (XENE) PT Lowered to $90 at Baird
- Xenon Pharmaceuticals (XENE) PT Lowered to $64 at Wells Fargo
- H.C. Wainwright Reiterates Buy Rating on Xenon Pharmaceuticals (XENE)
- Xenon Pharmaceuticals (XENE) PT Lowered to $70 at RBC Capital
- Deutsche Bank Downgrades Xenon Pharmaceuticals (XENE) to Hold
- Xenon files NDA for azetukalner in focal seizures, pauses psychiatry trials
- Xenon Announces Azetukalner NDA Submission to FDA for Focal Seizures and Provides Update on Psychiatry Clinical Program
- Xenon to Present at Wells Fargo Healthcare Conference
Entities mentioned with XENE
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Jefferies & Co | View Related Stories »
- Stifel | View Related Stories »
- 13G | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Show More...
